Details of Disease

Disease Name

Disease Class

N.A.: Toxicity

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DIS3KQVI: Toxicity

ICD-11

ICD-11: N.A.

General Information of Disease (ID: DIS3KQVI)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Edetate calcium disodium	DMLOKWU	Approved	Small molecular drug	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 2 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
P1A	DMWCAQD	Discontinued in Phase 2	Small molecular drug	[2]
Pifithrin-alpha	DM63OD7	Terminated	Small molecular drug	[3]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 8 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
DAV-121	DM1W6JQ	Investigative	NA	[4]
DAV-132	DMD7D18	Investigative	NA	[4]
ETV-004	DM2KQT9	Investigative	NA	[4]
LIM-0723	DMM3P1B	Investigative	NA	[4]
LIM-0744	DM5Y9DI	Investigative	NA	[4]
LIM-5310	DM2UBQ8	Investigative	NA	[5]
Non-PEGylated butyrylcholinesterase	DMMJFTR	Investigative	NA	[6]
UTL-5g	DM1O4HF	Investigative	NA	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020134)
3	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012866)
4	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
5	Limerick BioPharma, Inc. Pharmaceuticals & Healthcare. Deals and Alliances Profile. Limerick BioPharma, Inc. Nov-2014.
6	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2471).